Other Stories

Access Bio receives Brazil's authorization for test kits Updated: 2020-07-29 15:35:59 KST

The South Korean company Access Bio, which makes medical diagnostic tests, has been approved to send its COVID-19 test kits to Brazil having already been approved by the U.S. FDA.
The company said Wednesday that Brazil's drug safety ministry has approved them for emergency use.
These kits are understood to be able to detect the virus in under two hours.
With more than 2.4 million cases, Brazil is the country the pandemic's hit second hardest after the United States.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.